Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Oct 14, 2025
SAN MATEO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in three upcoming investor conferences.
Read more at globenewswire.com
